Literature DB >> 7911075

Restoration of lytic function in a human natural killer cell line by gene transfection.

J H Liu1, S Wei, D K Blanchard, J Y Djeu.   

Abstract

NK cells can recognize and lyse target cells without restriction by the MHC. The molecular interaction responsible for NK cell recognition is poorly understood. It has been frequently suggested that the loss of beta 2 integrin in immune competent cells may lead to dysfunction due to inadequate cell-cell interaction. We examined the role of lymphocyte functional adhesion molecule-1 in the function of a human natural killer leukemia cell line, YT-1. A mutant YT-1(-) cell subclone showed an absence of killing activity against a B lymphoma cell line, compared with that against a CD11a/CD18 positive parental cell line, YT-1(+) cells. We found that this loss of cytotoxicity was correlated with lack of surface expression of CD11a/CD18 molecules due to the mutation of the CD18 gene. Using gene transfer experiments, we provide strong evidence demonstrating that CD18 transfection to this mutant NK cell line, YT-1(-), restored the surface expression of CD11a/CD18, and this restoration was accompanied by reexpression of cytotoxic function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911075     DOI: 10.1006/cimm.1994.1150

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Practical NK cell phenotyping and variability in healthy adults.

Authors:  Laura S Angelo; Pinaki P Banerjee; Linda Monaco-Shawver; Joshua B Rosen; George Makedonas; Lisa R Forbes; Emily M Mace; Jordan S Orange
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

2.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Yaming Liang; Chen Liu; Julie Y Djeu; Bin Zhong; Thorsten Peters; Karin Scharffetter-Kochanek; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

4.  Introduction of shRNAs into human NK-like cell lines with retrovirus.

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Methods Mol Biol       Date:  2010

5.  Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2.

Authors:  S Wei; A M Gamero; J H Liu; A A Daulton; N I Valkov; J A Trapani; A C Larner; M J Weber; J Y Djeu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

Review 6.  Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.

Authors:  Mattias Carlsten; Richard W Childs
Journal:  Front Immunol       Date:  2015-06-10       Impact factor: 7.561

Review 7.  Immunotherapy with NK cells: recent developments in gene modification open up new avenues.

Authors:  Lisa Marie Reindl; Nawid Albinger; Tobias Bexte; Stephan Müller; Jessica Hartmann; Evelyn Ullrich
Journal:  Oncoimmunology       Date:  2020-09-02       Impact factor: 8.110

Review 8.  Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.

Authors:  Sandro Matosevic
Journal:  J Immunol Res       Date:  2018-09-17       Impact factor: 4.818

9.  MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma.

Authors:  Wendy M Kandell; Sarah S Donatelli; Thu Le Trinh; Alexandra R Calescibetta; Tina So; Nhan Tu; Danielle L Gilvary; Xianghong Chen; Pingyan Cheng; William A Adams; Yin-Kai Chen; Jinhong Liu; Julie Y Djeu; Sheng Wei; Erika A Eksioglu
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.